The Results are in…

The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2

Outflow sampling demonstrated 0% positive cultures for Aerobiotix Illuvia versus the control technology outflow of 40% of positive cultures.

The Results are in…

The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2

Outflow sampling demonstrated 0% positive cultures for Aerobiotix Illuvia versus the control technology outflow of 40% of positive cultures.

Helping Protect Patients and Staff on the COVID front lines

Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®) Designed for

  • Operating Rooms
  • Diagnostic, Treatment and Transition areas
  • Aerosol-generating procedures
  • ICU’s, ED’s L&D

Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087

"The Illuvia machine is part of our infection control protocol. We've been very happy with the machine and we've been very happy with the results."

Dr. Joe Rubino, Orthopedic Surgeon

"A cost effective, simple, and efficient solution to reducing infection rates and providing peace of mind that our OR air quality is being addressed."

Lindsey Wisniewski MHA, Chief Operating Officer/ Security and Compliance Officer of FASTMD

"Thanks for all you have done for our OR. I really appreciate your company for making a difference in our environment."

Beverly Lindsay, Director of Surgical Services, JFK Medical Center, Florida

"Eliminates at least 99.97% of bacteria in single-pass testing."

Center for Microbial Community Studies; Research Triangle Institute

"There is a good correlation between air contamination and joint sepsis rate."

OM Lidwell; Journal of Hospital Infection

"Reduces O.R. air bacterial levels by over 60%."

Surgical Infection Society National Meeting 2017

"Reduced the total and viable airborne particulates as well as colony forming units (CFU) per cubic meter in orthopaedic operating theatre."

– Surgical & Orthopaedic Research Laboratories University of New South Wales

"C-UVC units significantly reduce total and viable particle counts"

– The Journal of Arthroplasty, 2017

A consensus of 94% agree that the amount of airborne contamination in the active operating room should be minimized to prevent SSI/PJI.

– Second Annual International Consensus Meeting on Musculoskeletal Infection 2018

Keeping Hospitals Safe

Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®)

Hospital air is contaminated with airborne microbes which can cause dangerous surgical site infections. Learn how the Illuvia® system is keeping patients safe.

Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087

News and Events

News and Events

CLEANER AIR MEANS BETTER HEALTHCARE

Surgical site infections (SSIs) continue to constitute a significant fraction of hospital-acquired infections contributing to morbidity and mortality to healthcare systems globally. There are approximately 290,000 incidences of SSIs in the USA alone each year, translating into economic loss of $8.36 billion. A significant portion of SSIs have been proven to be airborne in origin and correlate with increased bacterial air content.

Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087

The International Consensus Meeting on Musculoskeletal Infection is the definitive meeting of global leaders in orthopedic infection. Chaired by Dr. Javad Parvizi, the latest meeting was July 2018 in Philadelphia and attended by over 400 delegates.

By a 94% consensus, these leaders stated that: “the amount of airborne contamination in the active operating room should be minimized to prevent surgical site infection/PJI.” Only Illuvia HUAIRS is designed to reduce the possibility of surgical infections by decontaminating intraoperative air with a combination of advanced ultraviolet and HEPA technologies.

Call Now to learn more about our solution the Illuvia® HUAIRS +1 888 978 7087

 

Contact Us

 

444 Alexandersville Rd
Miamisburg, Ohio 45342

info@aerobiotix.com
+1 888 978 7087

=